December 7, 2022 – Overcoming EZH2 Inhibitor Resistance for immunotherapy

[]D22 +7

Post author:aftaka
Post published:December 7, 2022
Post category:Potassium (KV) Channels

[]D22 +7.0 (0.1, MeOH); 1H NMR (300 MHz, CDCl3) 2.12 (ddd, = 3.6, 8.2, 13.5 Hz, 1H), 3.47-3.61 (m, 2H), 3.51 (s, overlapped, 3H), Bifenazate 3.87 (ddd, = 3.0, 5.1,…

[]D22 +7

Post author:aftaka
Post published:December 7, 2022
Post category:Potassium (KV) Channels

[]D22 +7.0 (0.1, MeOH); 1H NMR (300 MHz, CDCl3) 2.12 (ddd, = 3.6, 8.2, 13.5 Hz, 1H), 3.47-3.61 (m, 2H), 3.51 (s, overlapped, 3H), Bifenazate 3.87 (ddd, = 3.0, 5.1,…